CTOs on the Move

Florida Blue

www.bcbsfl.com

 
Florida Blue is a subsidiary of a not-for-profit health solutions company dedicated to serving all Floridians in the pursuit of health. Florida Blue is an independent licensee of the Blue Cross and Blue Shield Association, serving residents and businesses in the state of Florida.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.bcbsfl.com
  • 4800 Deerwood Campus Pkwy
    Jacksonville, FL USA 32246-6498
  • Phone: 904.791.6111

Executives

Name Title Contact Details
Ken Morris
Director - Information & Cyber Security (Interim CISO) Profile

Similar Companies

Siouxland Community Blood Bank

Siouxland Community Blood Bank is a Sioux City, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AIDS Commnty Rsrch Consortium

AIDS Commnty Rsrch Consortium is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pillo Health

Six in ten Americans live with at least one chronic condition, a leading driver of healthcare costs across the country. Medication non-adherence results in hundreds of billions in wasted costs annually and a higher mortality rate in the U.S. Pillo Health is tackling these issues head-on with an engaging and HIPAA-compliant technology platform dedicated to improving health outcomes for patients at home.

Research Diets

Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Naveos

NAVEOS® is the proven leader in maximizing the value of governmental program reimbursements for healthcare providers. Since 2005, our superior approach to data analytics has enabled healthcare providers to realize almost one billion dollars in additional DSH/340B reimbursement payments. NAVEOS® has developed a fully integrated DSH/340B software solution with a national eligibility verification network for both Medicare and Medicaid data. This system, which is the most robust in the industry, uses sophisticated algorithms to match eligibility data with patient data, applies the most up to date Federal and State regulatory parameters, then builds comprehensive deliverables for supporting DSH/340B filings. By leveraging our state-of-the-art technology and unsurpassed domain expertise, we generate best-in-class deliverables that yield impressive value and achieve a stellar (99.7%) audit acceptance rate.